Results 161 to 170 of about 61,613 (221)

Overcoming Resistance: Targeting Survivin-Driven Apoptotic Resistance Restores Irinotecan Sensitivity in <i>TP53</i>-Mutant Colorectal Cancer. [PDF]

Cancers (Basel)
Dumut DC, Xu YZ, Verelli D, Das V, Hajduch M, De Sanctis JB, Radzioch D.   +6 more
europepmc   +1 more source

Circulating tumour DNA to guide rechallenge with cetuximab plus irinotecan in RAS/BRAF wild-type metastatic colorectal cancer: A nonrandomised clinical trial. [PDF]

Clin Transl Med
Wang DS, Chen WC, Ren C, Wang FH, Wang ZQ, Luo HY, Wang F, Tan Q, Li YH.   +8 more
europepmc   +1 more source

Modulation of Drug Resistance and Apoptotic Pathways Underlies the Enhanced Antitumor Effect of Ellagic Acid-Irinotecan Combination in Glioma. [PDF]

Int J Mol Sci
Biltekin B, Çetin A.
europepmc   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]

Br J Clin Pharmacol
Chauhan D, Dello Russo C, Thompson J, Hughes DA, Payne K, Tsakiroglou M, Ross P, Chauhan R, Jenkinson S, Keen J, Harding S, Lau E, Braun M, Agarwal R, Adams R, Rolf E, Al-Sheikhli F, Mitchell S, Hammond R, Roberts R, Cairns L, Heggarty S, Graham J, Mencel J, Pirmohamed M.   +24 more
europepmc   +1 more source

Chidamide combined with dinutuximab beta, irinotecan and temozolomide for relapsed or refractory neuroblastoma in children: protocol for a prospective, single-centre, open-label, single-arm, phase II study in China. [PDF]

BMJ Open
Jin Y, Zhong B, Fu J, Liu J, Li J, Li Z, Gong B, Wang C, Man S, Li Z, Liu Y, Wang D, Yu J, Cao W, Zhao Q, Zhu X, Cao Y.   +16 more
europepmc   +1 more source

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation-Guided Irinotecan-Based Therapy in Metastatic Colorectal Cancer: A Case Report. [PDF]

Cureus
Julka PK, Arya D, Bhasir A, Gupta S.
europepmc   +1 more source

Design, Synthesis and Biological Evaluation of Novel SN38 Based Albumin-Binding Peptide-Drug Conjugates in Pancreatic Ductal Adenocarcinoma. [PDF]

Pharmaceutics
Su Y, Lu Y, Yu J, Jin C, Chen Y, Lu W, Ding J.   +6 more
europepmc   +1 more source

Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma. [PDF]

Cancer Res
Woo SM, Kang JH, Choi W, Lee H, Jang H, Sim SH, Chun JW, Koh EB, Kim C, Ham W, Hong W, Kang M, Park J, Han S, Kim JW, Lee EW, Lee WJ, Kim SY.   +17 more
europepmc   +1 more source